PB McGlave

Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression

WJ Miller, Kristin L.M. Boylan, PB McGlave · Blood · 1992 · 157 citations · Full text

Life Sciences, Hematology, Oncology +16

Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases [published erratum appears in Blood 1990 Aug 1;76(3):654]

PB McGlave, Paula Beatty, R Ash et al. · Blood · 1990 · 120 citations · Full text

Medicine, Hematology, Oncology +12

In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts [see comments]

BR Blazar, JH Kersey, PB McGlave et al. · Blood · 1989 · 110 citations · Full text

Medicine, Hematology, Immunology +14

Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture

Francisco Cervantes, BA Pierson, PB McGlave · Blood · 1996 · 87 citations · Full text

Life Sciences, Immunology, Oncology +11

BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients

Ravi Bhatia, Weston P. Miller, Frank Mortari et al. · Blood · 1996 · 62 citations · Full text

Medicine, Hematology, Oncology +13